Global Brain Metastasis Therapeutics Pipeline Report 2015 - 23 Companies & 33 Drug Profiles

. Buy Breast Health online Mobic (Meloxicam) DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/58tc2h/brain_metastasis) has announced the addition of the "Brain Metastasis - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Brain metastasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. http://future-pharmaceuticals.blogspot.com Etosid with free prescription Buy Vesicare (Solifenacin) with free prescription It also reviews key players involved in the therapeutic development for Brain metastasis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Buy Nolvadex (Tamoxifen) without prescription Buy Cialis Black (Tadalafil + L-Arginine + Giseng + Vitamin B6 + Folic Acid) with free prescription It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development AbbVie Inc. AngioChem Inc. BBB Therapeutics B.V. biOasis Technologies Inc. Bristol-Myers Squibb Company Diffusion Pharmaceuticals LLC e-Therapeutics Plc Exelixis, Inc. GlaxoSmithKline Plc Hutchison MediPharma Limited Komipharm International Co., Ltd. Nektar Therapeutics Nerviano Medical Sciences S.r.l. Novartis AG Oncothyreon Inc. Pfizer Inc. Philogen S.p.A. Phosplatin Therapeutics LLC Puma Biotechnology, Inc. Radius Health, Inc. Sanofi Spectrum Pharmaceuticals, Inc. Tocagen Inc. Drug Profiles dabrafenib mesylate + trametinib dimethyl sulfoxide 2B3-101 ANG-1005 ANG-4043 BT-2111 cabazitaxel cabozantinib s-malate ceritinib dacomitinib etirinotecan pegol ETS-2101 HMPL-813 ipilimumab irbinitinib KML-001 lucanthone hydrochloride MDNA-55 neratinib nimotuzumab NMSE-973 PB-357 PF-06463922 plinabulin PT-112 RAD-1901 radretumab RRX-001 TPI-287 transcrocetinate sodium Vaccine for Metastatic Brain Tumor veliparib vocimagene amiretrorepvec + flucytosine ER X-82 For more information visit .researchandmarkets.com/research/58tc2h/brain_metastasis